XML 52 R37.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Segment Reporting (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2018
Segment Reporting [Abstract] |
Summary of segment performance | The following is a summary of segment performance for the three and nine months ended September 30, 2018 and 2017 (in thousands): ໿ ໿ ໿
﻿ |  | For the Three Months Ended September 30,
﻿ |  | CAG |  | Water |  | LPD |  | Other |  | Unallocated Amounts |  | Consolidated Total
2018 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 478,097 |  |  | $ | 33,108 |  |  | $ | 29,420 |  |  | $ | 4,823 |  |  | $ | — |  |  | $ | 545,448 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
Income (loss) from operations |  | $ | 102,241 |  |  | $ | 15,874 |  |  | $ | 4,007 |  |  | $ | 443 |  |  | $ | (5,215 | ) |  | $ | 117,350 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  | (8,311 | )
Income before provision for income taxes |  |  |  |  |  |  |  |  |  |  |  | 109,039 |
Provision for income taxes |  |  |  |  |  |  |  |  |  |  |  | 15,825 |
Net income |  |  |  |  |  |  |  |  |  |  |  | 93,214 |
Less: Net loss attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  | (37 | )
Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  |  |  | $ | 93,251 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
2017 |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 426,686 |  |  | $ | 31,030 |  |  | $ | 28,396 |  |  | $ | 5,864 |  |  | $ | — |  |  | $ | 491,976 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
Income (loss) from operations |  | $ | 89,271 |  |  | $ | 14,505 |  |  | $ | 902 |  |  | $ | 2,114 |  |  | $ | (6,379 | ) |  | $ | 100,413 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  | (8,364 | )
Income before provision for income taxes |  |  |  |  |  |  |  |  |  |  |  | 92,049 |
Provision for income taxes |  |  |  |  |  |  |  |  |  |  |  | 21,535 |
Net income |  |  |  |  |  |  |  |  |  |  |  | 70,514 |
Less: Net income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  | 3 |
Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  |  |  | $ | 70,511 |
໿
﻿ |  | For the Nine Months Ended September 30,
﻿ |  | CAG |  | Water |  | LPD |  | Other |  | Unallocated Amounts |  | Consolidated Total
2018 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 1,456,417 |  |  | $ | 94,909 |  |  | $ | 96,658 |  |  | $ | 15,872 |  |  | $ | — |  |  | $ | 1,663,856 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
Income (loss) from operations |  | $ | 332,435 |  |  | $ | 43,458 |  |  | $ | 13,439 |  |  | $ | 2,071 |  |  | $ | (15,415 | ) |  | $ | 375,988 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  | (25,291 | )
Income before provision for income taxes |  |  |  |  |  |  |  |  |  |  |  | 350,697 |
Provision for income taxes |  |  |  |  |  |  |  |  |  |  |  | 59,327 |
Net income |  |  |  |  |  |  |  |  |  |  |  | 291,370 |
Less: Net loss attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  | (23 | )
Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  |  |  | $ | 291,393 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
2017 |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 1,269,861 |  |  | $ | 85,531 |  |  | $ | 91,266 |  |  | $ | 16,279 |  |  | $ | — |  |  | $ | 1,462,937 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
Income (loss) from operations |  | $ | 277,857 |  |  | $ | 38,421 |  |  | $ | 9,880 |  |  | $ | 3,275 |  |  | $ | (14,213 | ) |  | $ | 315,220 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  | (23,849 | )
Income before provision for income taxes |  |  |  |  |  |  |  |  |  |  |  | 291,371 |
Provision for income taxes |  |  |  |  |  |  |  |  |  |  |  | 66,392 |
Net income |  |  |  |  |  |  |  |  |  |  |  | 224,979 |
Less: Net income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  | 92 |
Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  |  |  | $ | 224,887 |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration